text_1: Fibroblast growth factor 21 protects against atherosclerosis by modulating adiponectin and SREBP2 levels.
text_2: Chronic treatment with adiponectin partially reverses atherosclerosis without obvious effects on hypercholesterolemia in FGF21-deficient apolipoprotein E(-/-) mice.